Exploring Innovative Means for Biologics Delivery – Dr. Frank Tagliaferri, Pace® Life Sciences
Alternative delivery methods for biologics continues to be explored that offer less invasive, less painful administration. Despite their track record […]
Life Sciences
Pace® Life Sciences Announces Compliant US FDA Inspection of Operations in Oakdale, MN
Proven track record of consistent high quality confirmed at Pace® Life Sciences headquarters MINNEAPOLIS, MN., July 25, 2024 (NEWSWIRE.COM): Pace®
Pace® Life Sciences Division Names Dean Bornilla as Head of Commercial
Bornilla brings over 25 years of commercial pharmaceutical experience to Pace® MINNEAPOLIS (July 23, 2024) – Pace® Life Sciences, a full-service
Pace Life Sciences gets positive FDA review at San Germán plant
Pace Life Sciences LLC, a central laboratory and contract development and manufacturing organization, received an “overall positive review” from the
Pace® Life Sciences Announces Successful Outcomes Following US FDA Inspection of Operations in San German, Puerto Rico
Long-standing reputation for robust quality is confirmed as company enters 2024 SAN GERMAN, PR., March 28, 2024 (NEWSWIRE.COM): Pace® Life
Pace® Life Sciences Acquires New Jersey Laboratory from Curia
Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network Minneapolis, MN [March 14, 2024] Pace® Life Sciences,
Pace® Life Sciences Appoints Dawn Von Rohr as Division President
Von Rohr brings over 25 years of experience to company Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO)
Analytical + Environmental
Crucial Role of Testing Labs in Pipeline Emergency Response
By John Gerken, Vice President of Corporate Accounts and Specialty Analytical Services, Pace (P&GJ) — Emergency situations, like explosions due
Pace® Life Sciences Adds Liquid Capsule Filling Technology
Pace® Life Sciences continues to make investments to broaden their comprehensive suite of oral solid dose development offerings. ANN ARBOR,
Life Sciences
Delnova Unveils Partnership With Pace® Life Sciences To Boost Capabilities
DelNova’s partnership will enable clinical development of its lead candidate ReViVox® for the rescue of undesirable outcomes which may arise